LionBio Therapeutics

LionBio Therapeutics is a consumer biotech and Columbia University spinout developing a nanoparticle platform for delivering peptide medicines through the nose, starting with a nasal GLP-1 (semaglutide). Its biodegradable polymer particles, based on scientific co-founder Kam Leong's drug-delivery research, are designed to carry peptides across the olfactory region of the upper nasal cavity toward the brain, aiming at better tolerability than injections and, longer term, neurological indications such as addiction, memory and sleep. Founded in 2026 by CEO Robin Guo, the company is preclinical, with unpublished animal data in mice and minks, rat pharmacokinetics underway and a first human study targeted for late 2027.

  • Pre-Seed
  • Biotechnology
  • Consumer Software
  • Peptide Therapeutics
  • Healthcare & Life Sciences

1

Round

1

Industry

4

Tags

Nov 5, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 5, 2026

    $6M

    Pre-Seed

    Led by South Park Commons

    • Andreessen Horowitz
    • Parable
    • Tactile Ventures
    • Adverb Ventures
    • South Park Commons

    Article coming soon.

Pricing

Research LionBio Therapeutics — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if LionBio Therapeutics is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational